Ziemelkurzemes regionala slimnica SIA
- Address
- Inzenieru Iela 60, 3601 Ventspils, Latvia
Ziemelkurzemes regionala slimnica SIA - Ophthalmology & Endocrinology Research Center
Ziemelkurzemes regionala slimnica SIA is a specialized clinical research facility with particular expertise in ophthalmological and endocrinological disorders. The center demonstrates significant experience in conducting advanced Phase 2 and Phase 3 clinical trials, with a strong focus on innovative biological therapies and biosimilar development. Their research portfolio reflects a commitment to evaluating cutting-edge treatments for complex eye and thyroid-related conditions.
- Retinal diseases and age-related macular degeneration, including wet AMD and macular neovascularization studies
- Thyroid Eye Disease (TED) research, including novel biological agents and long-term extension studies
- Autoimmune thyroid disorders, particularly Graves' Disease treatment development
- Gene therapy and biosimilar comparative effectiveness trials in ophthalmology
The center's ophthalmology research program is particularly notable for its involvement in biosimilar development and gene therapy trials, including studies of intravitreal injections and novel drug delivery systems. In the endocrinology domain, the facility has established expertise in Thyroid Eye Disease clinical research, conducting both dose-ranging studies and long-term maintenance trials with innovative subcutaneous biologics. This dual specialization positions the center as a valuable contributor to advancing treatment options for patients with vision-threatening and autoimmune conditions.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 4 by active trials.
- 1Immunovant Sciences GmbH2active
lock +3 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Immunovant Sciences GmbH4trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 80 other sites in Latvia
Therapeutic Area Benchmark — Latvia
Select a therapeutic area to compare against other sites in Latvia.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Latvia
Market Share
Country: Latvia
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Ziemelkurzemes regionala slimnica SIA
lock Showing 1 of 8 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Phase 2b Randomized Study of IMVT-1402 Versus Placebo in Adult Patients with Graves' Disease | Immunovant Sciences GmbH | Phase II | Recruiting | Nov 2025 | — |
IMP list
lock Showing 1 of 6 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Aflibercept | 2 | Unknown | 2025-12-09 | 2026-03-31 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.